Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease
Neurology
.
2018 Jan 16;90(3):144-145.
doi: 10.1212/WNL.0000000000004824.
Author
Fabrizio Piazza
1
Affiliation
1
(Monza, Italy).
PMID:
29335308
DOI:
10.1212/WNL.0000000000004824
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease*
Amyloid beta-Peptides
Humans
Immunoglobulins, Intravenous
Substances
Amyloid beta-Peptides
Immunoglobulins, Intravenous